Ivenix, Inc. is a medical technology company with a vision to eliminate infusion related patient harm. The company was founded to develop innovative solutions to transform infusion delivery. Ivenix designed an infusion system from the ground up to streamline medication delivery and bring legacy technology into the digital age. The Ivenix Infusion System includes a large volume infusion pump supported by a robust infusion management system designed to set new standards in usability, medication precision, and interoperability. The Ivenix Infusion System is currently under 510(k) review by the U.S. FDA.
Location: United States, Massachusetts, North Andover
Employees: 51-200
Phone: +1 978-775-8050
Total raised: $92M
Founded date: 2007
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.03.2017 | - | $50M | - |
| 01.09.2015 | - | $42M | - |
Mentions in press and media 6
| Date | Title | Description |
| 04.04.2022 | Digital health news, funding roundup in the prior week; April 4, 2022 | Hims & Hers and Carbon Health partner; White House's new COVID website; FDA approved second booster Top Health News CMS announced it will offer more than $110 million to expand access to home and community-based services through Medicai... |
| 19.10.2021 | Eastman Chemical : 2021, Oct 19 - Ivenix selects Eastman Tritan™ copolyester for its new infusion system | BOSTON and KINGSPORT, Tenn., Oct. 19, 2021 - Medical technology innovator Ivenix collaborated with Eastman to incorporate Eastman Tritan™ MXF copolyester into its groundbreaking Ivenix Infusion System. The new system includes a large-volume... |
| 21.03.2017 | Ivenix Closes on First Tranche of $50M Equity Financing | Ivenix, Inc., an Amesbury, Mass.-based medical technology company, closed on the first tranche of a $50m round of equity financing. The round was led by two new undisclosed investors, as well as participation from existing investors F-Prime... |
| 21.03.2017 | Ivenix Raises $50M to Pursue FDA Clearance of Next-Gen Infusion Pump System | Ivenix, a medical technology company developing the next-gen infusion system has raised $50 million in equity financing led by two new undisclosed investors, as well as participation from existing investors F-Prime Capital Partners and WuXi... |
| 01.09.2015 | Ivenix Closes $42M Round of Equity Financing | Ivenix Inc., an Amesbury, MA-based medical device company, closed on a $42M round of equity financing. The round was led by new investor WuXi Healthcare Ventures with participation from Cardinal Partners, CICA, Inc., Easterly Capital, Fidel... |
| 01.09.2015 | Ivenix Raises $42M | AMESBURY, MA, Ivenix closed on a $42M round of equity financing led by new investor WuXi Healthcare Ventures. >> Click here for more funding data on Ivenix >> To export Ivenix funding data to PDF and Excel, click here Car... |